Tag: Diabetes: Type I
Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to...
GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner
Low-Glucose Alerts Beneficial for Insulin-Treated Drivers With Diabetes
Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
Type 1 diabetes associated with less myocardial infarction, percutaneous coronary intervention, stroke, and limb ischemia
Body Weight Cycling Tied to Increased Risk for Renal Events in Type 1 Diabetes
Authors say that long-term weight maintenance should be a focus of this population
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data
Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
Reductions seen in median Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome score, Patient Assessment of Gastrointestinal Symptom Severity Index
Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DM
Regimen of inhaled Technosphere insulin plus insulin degludec noninferior for mean hemoglobin A1c
Automated Insulin Delivery System Improves Glycemic Control in Youth
Findings seen among children and adolescents with type 1 diabetes and nonoptimal control with traditional treatment
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity
